For individuals recovering from stroke, TBI, or aphasia, and the healthcare professionals managing their treatment.
Delivering AI-guided cognitive and speech therapy tools to support neurological recovery for patients and clinicians.
Target audience
Portfolio
Free 2Last updated
Constant Therapy: Brain+Speech
v8.3.1
3mo ago
Primary focus
Medical · Cognitive and speech rehabilitation
Scale
indie
Target audience
Individuals recovering from stroke, TBI, or aphasia, and the healthcare professionals managing their treatment.
Maintained an active development cycle with 5 updates across their 2-app portfolio in the last 6 months.
2 apps analysed
Proven cognitive, language, speech therapy for aphasia, dementia, stroke, TBI
Clinician Portal integrates the app into clinical workflows, driving institutional adoption and patient referrals.
For Speech-language therapists / SLPs, OTs: Aphasia, dementia, stroke, TBI care
Tightly focused on 3 markets (Mexico, Spain, United States).
Based on 1 of 2 apps with localized market data — more coverage rolling in as scans complete · last scanned .
1
Positive apps
0
Neutral / mixed
0
Negative apps
85/100
Avg sentiment score
Directly competes in the clinical-grade cognitive training space with a focus on neuroplasticity and evidence-based exercises.
Strategic outlook coming soon.
What fed this analysis
Occupies the broader brain-training category, serving as a mass-market alternative for cognitive maintenance.
Adjacent medical utility that captures the same chronic-care patient demographic through medication management.
Emerging as a strong competitor in digital therapeutics by focusing on AI-guided musculoskeletal and pain management.
Aggressive release velocity and AI-driven physical therapy positioning represent a significant shift toward automated clinical care.